Skip to content
miRecule, Inc. logo

miRecule, Inc. Alternatives & Competitors

12 companies similar to miRecule, Inc. — RNA Therapeutics

Companies similar to miRecule, Inc.

Dyne Therapeutics logo — alternative to miRecule, Inc.

Dyne Therapeutics

Advancing life-transforming therapies for serious muscle diseases

FREZENT Biological logo — alternative to miRecule, Inc.

FREZENT Biological

Preventing cancer recurrence

Elixirgen Therapeutics, Inc. logo — alternative to miRecule, Inc.

Elixirgen Therapeutics, Inc.

Reimagine the Power of RNA

AIRNA logo — alternative to miRecule, Inc.

AIRNA

The next generation of RNA editing therapeutics

Rival Readout

Competing with miRecule, Inc.? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
Onchilles Pharma logo — alternative to miRecule, Inc.

Onchilles Pharma

Developing drug candidates that have the potential to be broadly effective against a wide...

Rgenta Therapeutics Inc. logo — alternative to miRecule, Inc.

Rgenta Therapeutics Inc.

We unlock the therapeutic potentials of highly disease-relevant targets undruggable by sma...

Rakuten Medical logo — alternative to miRecule, Inc.

Rakuten Medical

Rakuten Medical, Inc. is a global biotechnology company in pursuit of conquering cancer.

Kynexis logo — alternative to miRecule, Inc.

Kynexis

Kynexis is advancing the first potential precision medicine for the treatment of CIAS.

Elevation Oncology logo — alternative to miRecule, Inc.

Elevation Oncology

We are focused on discovering and developing selective cancer therapies to treat patients...

NextPoint Therapeutics, Inc. logo — alternative to miRecule, Inc.

NextPoint Therapeutics, Inc.

Launching a new world of precision therapeutics through its leading scientific work on th...

Crossbow Therapeutics, Inc logo — alternative to miRecule, Inc.

Crossbow Therapeutics, Inc

Established antibody engineering to target the untapped universe of intracellular cancer t...

Systems Oncology logo — alternative to miRecule, Inc.

Systems Oncology

Deeper Insights, Multimodal Drugs - We translate genomic intelligence into multi-targeting...

About miRecule, Inc.

miRecule, Inc., a promising player in the RNA Therapeutics domain, is pioneering first-in-class RNA-based therapies, focusing on conditions such as Head & Neck Squamous Cell Carcinoma (HNSCC) and Facioscalpulohumeral Muscular Dystrophy (FSHD). Established in 2016, this United States-based startup operates within the Bi...

Services

Development of RNA therapies for cancer and muscular dystrophy, Creation of antibody RNA conjugate therapeutics, Utilization of genomic and outcome data for therapeutic development, Expansion of strategic collaborations (e.g., with Sanofi)

Target Customers

Patients with cancer, Patients with muscular dystrophy, Patients suffering from neuromuscular diseases, Healthcare providers specializing in rare genetic diseases

Business keywords

RNA Therapeutics, First-in-Class Therapies, Head & Neck Squamous Cell Carcinoma, Facioscapulohumeral Muscular Dystrophy, Genomic Patient Data, Tailored Therapeutics, DREAmiR™ Platform, Genetic Alteration Targeting, RNA Therapeutics Development, Antibody RNA Conjugate (ARC), Genomic Medicine, Cancer Therapies, Muscular Dystrophy Therapies, Precision Medicine

Business Model

B2B, B2D, B2B2B

Revenue Model

Licensing, Performance Based, Product Sales

Frequently Asked Questions

Companies similar to miRecule, Inc. include Dyne Therapeutics, FREZENT Biological, Elixirgen Therapeutics, Inc., AIRNA, Onchilles Pharma. They work in Biotechnology and Health Care and share miRecule, Inc.'s focus on precision medicine, cancer therapies and facioscapulohumeral muscular dystrophy.
Bounce Watch lists 12 companies that share miRecule, Inc.'s industries and are closest to it in business tags, services, target customers, business model and size.
miRecule, Inc., a promising player in the RNA Therapeutics domain, is pioneering first-in-class RNA-based therapies, focusing on conditions such as Head & Neck Squamous Cell Carcinoma (HNSCC) and Facioscalpulohumeral Muscular Dystrophy (FSHD). Established in 2016, this United States-based startup operates within the Bi...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around miRecule, Inc.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at miRecule, Inc. on 11 Mar 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout